Nadiya Oleksiv
Optometrist · Portsmouth, NHNPI 1821448168
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,399 of the $3,093 with a category attached, or 77.6%. 14 manufacturers reported payments, led by Coopervision Inc. at 35.5% of the total. Reporting peaked in 2019 at $1,094 and has fallen 78.5% since, to $235 in 2025. Among optometrist clinicians in NH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 67 payments — averaging $46.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopervision Inc.$1K
- AbbVie$699
- Alcon$409
- Bausch & Lomb, A Division Of Bausch Health US, LLC$161
- Novartis$120
- Oyster Point Pharma, Inc.$115
- plus $491 from 8 others
What the payments were for
- Speaking & faculty fees$69422%
- Food & beverage$2,39978%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coopervision Inc. | 13 | $1,099 |
| AbbVie(2 entities) | 26 | $699 |
| Alcon | 6 | $409 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $161 |
| Novartis | 1 | $120 |
| Oyster Point Pharma, Inc. | 4 | $115 |
| Astellas Pharma US Inc | 1 | $103 |
| Bausch & Lomb Americas Inc. | 4 | $93 |
| Shire North American Group Inc | 1 | $93 |
| Sun Pharmaceutical Industries Inc. | 3 | $80 |
| Sight Sciences, Inc. | 2 | $42 |
| Dompe US, Inc. | 1 | $31 |
| Johnson & Johnson Vision Care, Inc. | 1 | $25 |
| Quidel Corporation | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VUITY$232
- Rhopressa$146
- Rocklatan$146
- TOTAL30$129
- XIIDRA$120
- BIOTRUE$119
- ULTRA$119
- BIOTRUE ONE DAY$119
- Multiple Brands Contact Lens$108
- Izervay$103
How this compares
$3,093 in reported general payments places this provider in the 90th percentile of 235 optometrist providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 25 | $212 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Portsmouth
- Lauren McLoughlinPortsmouth$138K
- Sarah HudsonPortsmouth$6K
- Renee LynchPortsmouth$5K
- Rinita TrahanPortsmouth$5K
- Jill FedericoPortsmouth$5K
- Puneet HarisinghaniPortsmouth$4K
- Christopher TurnerPortsmouth$2K
- Marcy SchultenoverPortsmouth$2K
- Nikolas MoorePortsmouth$2K
- Janet RandPortsmouth$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.